Nhat M Pham, MD
Internal Medicine · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 13
- 4 carriers
- Office
- 1
Offices
1 location · County of Santa Clara · 1,000 clinicians in this group
Hospitals listed: 052305 · 052572 · 552723 · Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
13 plans · 4 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Pham’s office at (408) 885-5000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
13 of 13 plans
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A79286 · Current
Licensed to practise in California · since 2002 · expires 2027-11-30 · University of California San Francisco School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 80.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$117,257
Medicare paid this office $117,257 for 162 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Dialysis services, 1 physician visit per month (20 years or older) | 40 | $36,451 | $187 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 15 | $16,269 | $271 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 39 | $11,078 | $104 |
| Return visit (30+ min) | 45 | $8,007 | $86 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 35 | $4,685 | $69 |
See all 7 services
| Dialysis services, 1 physician visit per month (20 years or older) | 40 | $36,451 | $187 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 15 | $16,269 | $271 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 39 | $11,078 | $104 |
| Return visit (30+ min) | 45 | $8,007 | $86 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 35 | $4,685 | $69 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 24 | $2,936 | $113 |
| Hemodialysis procedure with physician evaluation | 15 | $1,212 | $64 |
Who their Medicare patients are
162 Original Medicare patients in 2024. Average age 68 · Under 65 33% · 85 and older 11% · Women 46% · Also on Medicaid 86% · Health risk score 7.36. Sicker patients than 9 in 10 peers; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 75% · Diabetes 75% · Chronic kidney disease 75% · Heart failure 51% · Coronary heart disease 48% · Atrial fibrillation 31% · Depression 25% · Stroke 23% · COPD 18% · Dementia 16% · Cancer 10%.
The office billed $1,130,914, Medicare allowed $149,775 and paid $117,257; for 740 services of 14 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 162 | 740 | 68 | 7.36 | $1,130,914 | $117,257 |
| 2023 | 158 | 682 | 68 | 6.40 | $978,047 | $102,110 |
| 2022 | 191 | 784 | 68 | 5.59 | $1,058,417 | $108,423 |
| 2021 | 185 | 794 | 67 | 5.91 | $1,069,548 | $111,451 |
| 2020 | 221 | 965 | 66 | 6.23 | $1,130,740 | $128,160 |
| 2019 | 251 | 1,222 | 65 | 6.21 | $919,312 | $134,113 |
| 2018 | 274 | 1,312 | 66 | 5.58 | $1,015,014 | $146,178 |
| 2017 | 270 | 1,339 | 64 | 5.75 | $978,071 | $141,845 |
| 2015 | 156 | 301 | 65 | 6.39 | $260,961 | $32,399 |
| 2014 | 330 | 1,382 | 64 | 4.61 | $986,610 | $141,859 |
| 2013 | 269 | 1,077 | 64 | 5.03 | $843,164 | $120,269 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 8 services
| Dialysis services, 1 physician visit per month (20 years or older) | 33 | $32,859 | $183 |
| Home dialysis services per month (20 years or older) | 12 | $20,673 | $268 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 15 | $16,687 | $269 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 36 | $12,286 | $110 |
| Return visit (30+ min) | 52 | $9,476 | $82 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 35 | $3,575 | $73 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 12 | $2,079 | $160 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $1,794 | $120 |
2022: 7 services
| Dialysis services, 1 physician visit per month (20 years or older) | 39 | $38,450 | $185 |
| Home dialysis services per month (20 years or older) | 12 | $22,724 | $267 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 52 | $14,580 | $94 |
| Return visit (30+ min) | 87 | $12,827 | $82 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 22 | $4,735 | $182 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 25 | $3,502 | $66 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 17 | $2,117 | $125 |
2021: 10 services
| Dialysis services, 1 physician visit per month (20 years or older) | 50 | $40,024 | $194 |
| Home dialysis services per month (20 years or older) | 12 | $20,797 | $274 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 18 | $15,848 | $273 |
| Return visit (30+ min) | 53 | $9,275 | $76 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 32 | $9,161 | $95 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 37 | $7,301 | $66 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 17 | $3,330 | $185 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 21 | $2,881 | $120 |
| Hemodialysis procedure with physician evaluation | 11 | $742 | $67 |
| Short return visit (20+ min) | 12 | $440 | $31 |
2020: 12 services
| Dialysis services, 1 physician visit per month (20 years or older) | 57 | $52,660 | $174 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 30 | $25,258 | $222 |
| Home dialysis services per month (20 years or older) | 14 | $16,133 | $224 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 35 | $8,079 | $97 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 39 | $5,688 | $68 |
| Return visit (30+ min) | 58 | $5,536 | $58 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 29 | $5,470 | $189 |
| Telephone medical discussion with physician, 11-20 minutes | 40 | $2,283 | $45 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 16 | $2,182 | $128 |
| New patient visit (45+ min) | 13 | $1,446 | $111 |
| Hemodialysis procedure with physician evaluation | 14 | $1,371 | $69 |
| Short return visit (20+ min) | 24 | $1,161 | $45 |
2019: 11 services
| Dialysis services, 1 physician visit per month (20 years or older) | 79 | $49,448 | $164 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 23 | $25,209 | $217 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 57 | $13,638 | $95 |
| Return visit (30+ min) | 66 | $10,770 | $60 |
| Home dialysis services per month (20 years or older) | 11 | $10,072 | $214 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 51 | $6,761 | $66 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 31 | $6,081 | $184 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 35 | $4,845 | $124 |
| Hemodialysis procedure with physician evaluation | 41 | $4,264 | $67 |
| New patient visit (45+ min) | 15 | $1,066 | $71 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 15 | $955 | $7 |
2018: 10 services
| Dialysis services, 1 physician visit per month (20 years or older) | 65 | $49,865 | $163 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 23 | $32,709 | $214 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 56 | $14,137 | $94 |
| Return visit (30+ min) | 85 | $12,249 | $57 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 46 | $8,550 | $182 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 43 | $5,164 | $65 |
| Hemodialysis procedure with physician evaluation | 40 | $4,286 | $65 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 20 | $2,200 | $110 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 17 | $1,069 | $7 |
| Short return visit (20+ min) | 11 | $712 | $37 |
2017: 11 services
| Dialysis services, 1 physician visit per month (20 years or older) | 74 | $43,583 | $158 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 27 | $24,292 | $208 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 57 | $18,229 | $93 |
| Return visit (30+ min) | 73 | $13,291 | $62 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 65 | $10,624 | $65 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 48 | $10,334 | $181 |
| Hemodialysis procedure with physician evaluation | 33 | $3,155 | $64 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 17 | $2,075 | $122 |
| Short return visit (20+ min) | 23 | $1,552 | $39 |
| New patient visit (45+ min) | 12 | $1,138 | $95 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 16 | $1,092 | $8 |
2015: 6 services
| Dialysis services, 1 physician visit per month (20 years or older) | 50 | $11,639 | $144 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 22 | $6,236 | $189 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 14 | $3,483 | $85 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 26 | $2,731 | $58 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $1,946 | $150 |
| Return visit (30+ min) | 32 | $1,354 | $39 |
2014: 12 services
| Dialysis services, 1 physician visit per month (20 years or older) | 68 | $32,382 | $160 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 32 | $19,969 | $208 |
| Home dialysis services per month (20 years or older) | 13 | $16,095 | $209 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 71 | $14,676 | $91 |
| Return visit (30+ min) | 89 | $13,770 | $59 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 72 | $13,684 | $175 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 94 | $13,609 | $63 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 27 | $3,599 | $120 |
| Hemodialysis procedure with physician evaluation | 23 | $2,000 | $65 |
| Short return visit (20+ min) | 23 | $1,317 | $40 |
| New patient visit (45+ min) | 16 | $1,166 | $73 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 19 | $702 | $8 |
2013: 11 services
| Dialysis services, 1 physician visit per month (20 years or older) | 67 | $39,089 | $159 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 43 | $18,469 | $203 |
| Return visit (30+ min) | 90 | $14,250 | $56 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 11 | $11,396 | $242 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 50 | $6,175 | $61 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 26 | $4,492 | $173 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 25 | $4,415 | $88 |
| New patient visit (45+ min) | 21 | $2,130 | $101 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,768 | $110 |
| Short return visit (20+ min) | 16 | $1,081 | $40 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 14 | $547 | $7 |
Medicaid work
$6,600 in 2024
Medicaid paid $6,600 for 598 billed services this clinician did in 2024, up to 30 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 1 face-to-face visit by a physician or other qualified health care professional per month | 252 | $4,189 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 122 | $1,486 |
| Return visit (30+ min) | 147 | $744 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 12 | $110 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 65 | $73 |
| 2024 | 598 | 5 | 30 | $6,600 |
| 2023 | 731 | 5 | 32 | $12,472 |
| 2022 | 758 | 4 | 37 | $9,624 |
| 2021 | 810 | 7 | 41 | $14,726 |
| 2020 | 824 | 7 | 47 | $13,375 |
| 2019 | 1,185 | 9 | 58 | $13,288 |
| 2018 | 1,227 | 8 | 43 | $16,463 |
See the largest Medicaid services in earlier years
2023
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 1 face-to-face visit by a physician or other qualified health care professional per month | 274 | $7,947 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 70 | $1,607 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 181 | $1,586 |
| Return visit (30+ min) | 167 | $1,038 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 39 | $295 |
2022
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 1 face-to-face visit by a physician or other qualified health care professional per month | 312 | $5,667 |
| Return visit (30+ min) | 256 | $2,010 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 160 | $1,466 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 30 | $481 |
2021
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 1 face-to-face visit by a physician or other qualified health care professional per month | 294 | $8,518 |
| Return visit (30+ min) | 230 | $2,647 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 117 | $1,771 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 116 | $1,303 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 12 | $177 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 14 | $165 |
| 1ST HOSP IP/OBS HIGH 75 | 27 | $144 |
2020
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 1 face-to-face visit by a physician or other qualified health care professional per month | 381 | $7,918 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 109 | $1,931 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 114 | $967 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 81 | $880 |
| Return visit (30+ min) | 82 | $839 |
| 1ST HOSP IP/OBS HIGH 75 | 37 | $794 |
| Short return visit (20+ min) | 20 | $47 |
2019
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 1 face-to-face visit by a physician or other qualified health care professional per month | 370 | $4,752 |
| Return visit (30+ min) | 298 | $3,065 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 193 | $2,392 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 93 | $957 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 71 | $928 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 78 | $504 |
| 1ST HOSP IP/OBS HIGH 75 | 16 | $338 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 19 | $234 |
| OFF/OP EST MAY X REQ PHY/QHP | 47 | $118 |
2018
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 1 face-to-face visit by a physician or other qualified health care professional per month | 345 | $5,939 |
| Return visit (30+ min) | 363 | $4,500 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 139 | $1,680 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 115 | $1,457 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 91 | $1,323 |
| 1ST HOSP IP/OBS HIGH 75 | 48 | $814 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 88 | $671 |
| OFF/OP EST MAY X REQ PHY/QHP | 38 | $81 |
Drugs they prescribed that Part D paid
$214,989
Pharmacies billed $214,989 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,718) in 2024. At or below the middle of the specialty; the typical internal medicine clinician is at 1%.
1,458 generic and 237 brand-name prescriptions · $214,989 in drug cost · 11 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Lokelma | 35 | $30,407 | $869 |
| Renvela | 15 | $25,194 | $1,680 |
| Veltassa | 16 | $15,294 | $956 |
| Sevelamer Carbonate | 63 | $13,142 | $209 |
| Eliquis | 17 | $12,755 | $750 |
See all 35 drugs
| Lokelma | 35 | $30,407 | $869 |
| Renvela | 15 | $25,194 | $1,680 |
| Veltassa | 16 | $15,294 | $956 |
| Sevelamer Carbonate | 63 | $13,142 | $209 |
| Eliquis | 17 | $12,755 | $750 |
| Calcium Acetate | 111 | $11,519 | $104 |
| Cinacalcet | 28 | $4,072 | $145 |
| Tacrolimus | 23 | $2,867 | $125 |
| Furosemide | 131 | $1,911 | $15 |
| Febuxostat | 31 | $1,482 | $48 |
| Losartan | 179 | $1,479 | $8 |
| Metolazone | 13 | $1,432 | $110 |
| Sps | 13 | $1,428 | $110 |
| Bumetanide | 21 | $1,380 | $66 |
| Midodrine | 18 | $1,340 | $74 |
| Isosorbide Dinitrate | 11 | $919 | $84 |
| Carvedilol | 136 | $905 | $7 |
| Mycophenolate Mofetil | 16 | $862 | $54 |
| Amlodipine Besylate | 103 | $790 | $8 |
| Doxazosin Mesylate | 32 | $638 | $20 |
| Gentamicin Sulfate | 24 | $495 | $21 |
| Gabapentin | 69 | $478 | $7 |
| Lactulose | 54 | $420 | $8 |
| Atorvastatin | 64 | $403 | $6 |
| Pantoprazole | 47 | $342 | $7 |
| Omeprazole | 25 | $300 | $12 |
| Nifedipine Er | 18 | $285 | $16 |
| Famotidine | 29 | $236 | $8 |
| Metoprolol | 23 | $219 | $10 |
| Fosinopril | 12 | $204 | $17 |
| Hydralazine | 13 | $185 | $14 |
| Prednisone | 25 | $183 | $7 |
| Fluticasone Propionate | 22 | $166 | $8 |
| Hydrochlorothiazide | 22 | $62 | $3 |
| Hydroxyzine | 11 | $47 | $4 |
Year by year
| 2024 | 1,718 | 139 | 0% (0) | 14% | $214,989 |
| 2023 | 1,726 | 142 | 0% (0) | 12% | $356,299 |
| 2022 | 1,943 | 172 | 0% (0) | 13% | $340,446 |
| 2021 | 1,976 | 171 | 0% (0) | 18% | $314,334 |
| 2020 | 2,270 | 190 | None | None | $338,283 |
| 2019 | 2,204 | 193 | None | None | $414,536 |
| 2018 | 2,245 | 206 | None | None | $451,578 |
| 2017 | 2,364 | 222 | None | 28% | $662,749 |
| 2016 | 2,031 | 213 | 1% (12) | 26% | $679,091 |
| 2015 | 2,156 | 206 | 2% (33) | 27% | $557,911 |
| 2014 | 1,839 | 179 | 2% (41) | 24% | $403,977 |
| 2013 | 1,787 | 185 | 1% (18) | 30% | $354,242 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 33 drugs
| Auryxia | 11 | $72,523 | $6,593 |
| Renvela | 18 | $54,745 | $3,041 |
| Sevelamer Carbonate | 64 | $29,000 | $453 |
| Cinacalcet | 19 | $21,725 | $1,143 |
| Calcium Acetate | 83 | $8,822 | $106 |
| Eliquis | 14 | $8,387 | $599 |
| Sps | 31 | $7,721 | $249 |
| Tacrolimus | 21 | $7,105 | $338 |
| Losartan | 177 | $5,583 | $32 |
| Furosemide | 177 | $4,554 | $26 |
| Carvedilol | 156 | $4,425 | $28 |
| Novolog | 12 | $3,860 | $322 |
| Midodrine | 18 | $3,460 | $192 |
| Gabapentin | 87 | $2,548 | $29 |
| Febuxostat | 19 | $2,123 | $112 |
| Doxazosin Mesylate | 21 | $1,931 | $92 |
| Atorvastatin | 86 | $1,784 | $21 |
| Amlodipine Besylate | 133 | $1,782 | $13 |
| Mycophenolate Mofetil | 19 | $1,484 | $78 |
| Isosorbide Dinitrate | 14 | $1,090 | $78 |
| Gentamicin Sulfate | 30 | $1,013 | $34 |
| Omeprazole | 21 | $881 | $42 |
| Pantoprazole | 29 | $786 | $27 |
| Famotidine | 25 | $686 | $27 |
| Hydralazine | 20 | $600 | $30 |
| Calcitriol | 16 | $570 | $36 |
| Clonidine | 11 | $507 | $46 |
| Metoprolol | 20 | $381 | $19 |
| Lactulose | 41 | $333 | $8 |
| Prednisone | 15 | $245 | $16 |
| Allopurinol | 13 | $162 | $12 |
| Hydrochlorothiazide | 31 | $141 | $5 |
| Ondansetron | 11 | $88 | $8 |
2022: 42 drugs
| Velphoro | 12 | $73,458 | $6,122 |
| Renvela | 20 | $51,278 | $2,564 |
| Sevelamer Carbonate | 48 | $37,872 | $789 |
| Calcium Acetate | 90 | $15,881 | $176 |
| Eliquis | 18 | $9,188 | $510 |
| Retacrit | 12 | $8,082 | $673 |
| Febuxostat | 22 | $7,697 | $350 |
| Tacrolimus | 42 | $5,857 | $139 |
| Midodrine | 12 | $5,241 | $437 |
| Sps | 26 | $4,694 | $181 |
| Furosemide | 206 | $4,435 | $22 |
| Novolog | 12 | $3,735 | $311 |
| Carvedilol | 193 | $3,134 | $16 |
| Losartan | 160 | $2,122 | $13 |
| Bumetanide | 13 | $1,585 | $122 |
| Gabapentin | 78 | $1,520 | $19 |
| Potassium Chloride | 27 | $1,501 | $56 |
| Mycophenolate Mofetil | 20 | $1,222 | $61 |
| Amlodipine Besylate | 154 | $1,198 | $8 |
| Atorvastatin | 95 | $1,052 | $11 |
| Hydralazine | 45 | $988 | $22 |
| Doxazosin Mesylate | 15 | $973 | $65 |
| Isosorbide Dinitrate | 16 | $712 | $44 |
| Isosorbide Mononitrate Er | 17 | $670 | $39 |
| Omeprazole | 26 | $653 | $25 |
| Gentamicin Sulfate | 18 | $601 | $33 |
| Famotidine | 25 | $492 | $20 |
| Pantoprazole | 31 | $466 | $15 |
| Calcitriol | 20 | $465 | $23 |
| Fosinopril | 17 | $381 | $22 |
| Lactulose | 40 | $251 | $6 |
| Hydrochlorothiazide | 28 | $245 | $9 |
| Metoprolol | 27 | $228 | $8 |
| Clonidine | 13 | $224 | $17 |
| Heparin | 23 | $205 | $9 |
| Allopurinol | 12 | $204 | $17 |
| Ondansetron | 14 | $204 | $15 |
| Tamsulosin | 11 | $200 | $18 |
| Metoprolol | 15 | $162 | $11 |
| Trazodone | 12 | $159 | $13 |
| Hydroxyzine | 12 | $116 | $10 |
| Insulin | 15 | $36 | $2 |
2021: 42 drugs
| Renvela | 17 | $67,855 | $3,991 |
| Auryxia | 13 | $61,563 | $4,736 |
| Velphoro | 13 | $54,258 | $4,174 |
| Sevelamer Carbonate | 60 | $19,163 | $319 |
| Calcium Acetate | 90 | $17,887 | $199 |
| Febuxostat | 28 | $9,601 | $343 |
| Procrit | 11 | $9,358 | $851 |
| Sps | 44 | $8,824 | $201 |
| Retacrit | 14 | $6,952 | $497 |
| Eliquis | 11 | $6,302 | $573 |
| Furosemide | 281 | $4,446 | $16 |
| Novolog | 14 | $4,309 | $308 |
| Carvedilol | 175 | $2,167 | $12 |
| Losartan | 165 | $2,108 | $13 |
| Potassium Chloride | 41 | $1,735 | $42 |
| Tacrolimus | 17 | $1,232 | $72 |
| Atorvastatin | 78 | $994 | $13 |
| Hydralazine | 40 | $900 | $22 |
| Amlodipine Besylate | 131 | $861 | $7 |
| Metoprolol | 56 | $821 | $15 |
| Gabapentin | 67 | $724 | $11 |
| Isosorbide Mononitrate Er | 20 | $610 | $30 |
| Calcitriol | 26 | $579 | $22 |
| Gentamicin Sulfate | 15 | $504 | $34 |
| Lidocaine-Prilocaine | 16 | $503 | $31 |
| Doxazosin Mesylate | 19 | $501 | $26 |
| Fosinopril | 18 | $497 | $28 |
| Pantoprazole | 26 | $427 | $16 |
| Pravastatin | 11 | $366 | $33 |
| Lactulose | 35 | $246 | $7 |
| Omeprazole | 17 | $222 | $13 |
| Mycophenolate Mofetil | 11 | $207 | $19 |
| Heparin | 31 | $185 | $6 |
| Metoprolol | 14 | $178 | $13 |
| Hydrochlorothiazide | 31 | $175 | $6 |
| Tamsulosin | 18 | $172 | $10 |
| Allopurinol | 12 | $171 | $14 |
| Clonidine | 13 | $128 | $10 |
| Famotidine | 16 | $116 | $7 |
| Benazepril | 11 | $106 | $10 |
| Prednisone | 15 | $84 | $6 |
| Insulin | 17 | $28 | $2 |
2020: 42 drugs
| Renvela | 26 | $91,343 | $3,513 |
| Auryxia | 18 | $47,649 | $2,647 |
| Velphoro | 14 | $43,910 | $3,136 |
| Sevelamer Carbonate | 83 | $22,863 | $275 |
| Calcium Acetate | 110 | $21,386 | $194 |
| Cinacalcet | 16 | $9,711 | $607 |
| Retacrit | 14 | $6,984 | $499 |
| Sps | 53 | $6,858 | $129 |
| Atovaquone | 11 | $6,637 | $603 |
| Furosemide | 277 | $4,270 | $15 |
| Tacrolimus | 19 | $4,084 | $215 |
| Novolog | 13 | $3,873 | $298 |
| Veltassa | 12 | $2,711 | $226 |
| Losartan | 205 | $2,502 | $12 |
| Carvedilol | 208 | $2,307 | $11 |
| Hydralazine | 69 | $1,855 | $27 |
| Potassium Chloride | 39 | $1,723 | $44 |
| Atorvastatin | 108 | $1,146 | $11 |
| Amlodipine Besylate | 169 | $1,020 | $6 |
| Lidocaine-Prilocaine | 20 | $980 | $49 |
| Gentamicin Sulfate | 27 | $961 | $36 |
| Isosorbide Mononitrate Er | 26 | $741 | $29 |
| Metoprolol | 41 | $654 | $16 |
| Calcitriol | 18 | $554 | $31 |
| Pantoprazole | 28 | $523 | $19 |
| Gabapentin | 45 | $502 | $11 |
| Metoprolol | 15 | $481 | $32 |
| Heparin | 43 | $409 | $10 |
| Fosinopril | 25 | $403 | $16 |
| Mycophenolate Mofetil | 13 | $375 | $29 |
| Pravastatin | 12 | $369 | $31 |
| Omeprazole | 36 | $368 | $10 |
| Levothyroxine | 14 | $352 | $25 |
| Lactulose | 26 | $288 | $11 |
| Hydrochlorothiazide | 39 | $265 | $7 |
| Prednisone | 16 | $202 | $13 |
| Hydroxyzine | 19 | $186 | $10 |
| Famotidine | 20 | $163 | $8 |
| Tamsulosin | 22 | $157 | $7 |
| Allopurinol | 16 | $143 | $9 |
| Clonidine | 13 | $129 | $10 |
| Benazepril | 12 | $119 | $10 |
2019: 41 drugs
| Renvela | 39 | $151,813 | $3,893 |
| Sevelamer Carbonate | 94 | $87,138 | $927 |
| Velphoro | 11 | $34,415 | $3,129 |
| Veltassa | 28 | $18,170 | $649 |
| Calcium Acetate | 86 | $14,237 | $166 |
| Tacrolimus | 16 | $4,952 | $309 |
| Clinisol | 29 | $4,817 | $166 |
| Furosemide | 262 | $4,019 | $15 |
| Epogen | 11 | $2,673 | $243 |
| Sps | 44 | $2,102 | $48 |
| Potassium Chloride | 40 | $1,919 | $48 |
| Losartan | 187 | $1,893 | $10 |
| Hydralazine | 69 | $1,827 | $26 |
| Carvedilol | 147 | $1,640 | $11 |
| Atorvastatin | 106 | $1,259 | $12 |
| Amlodipine Besylate | 169 | $1,217 | $7 |
| Calcitriol | 26 | $940 | $36 |
| Gabapentin | 76 | $856 | $11 |
| Sodium Polystyrene Sulfonate | 13 | $841 | $65 |
| Nifedipine Er | 12 | $747 | $62 |
| Fosinopril | 34 | $739 | $22 |
| Metoprolol | 72 | $724 | $10 |
| Metoprolol | 20 | $712 | $36 |
| Ventolin Hfa | 12 | $671 | $56 |
| Gentamicin Sulfate | 18 | $649 | $36 |
| Isosorbide Mononitrate Er | 24 | $616 | $26 |
| Pravastatin | 12 | $579 | $48 |
| Lidocaine-Prilocaine | 23 | $546 | $24 |
| Pantoprazole | 23 | $435 | $19 |
| Omeprazole | 28 | $389 | $14 |
| Clonidine | 16 | $343 | $21 |
| Lactulose | 28 | $302 | $11 |
| Tamsulosin | 19 | $298 | $16 |
| Benazepril | 13 | $165 | $13 |
| Heparin | 28 | $156 | $6 |
| Allopurinol | 13 | $132 | $10 |
| Famotidine | 17 | $89 | $5 |
| Hydroxyzine | 11 | $75 | $7 |
| Hydrochlorothiazide | 11 | $64 | $6 |
| Alendronate | 11 | $59 | $5 |
| Cephalexin | 13 | $45 | $3 |
2018: 39 drugs
| Renvela | 57 | $202,476 | $3,552 |
| Sevelamer Carbonate | 38 | $50,487 | $1,329 |
| Sensipar | 30 | $36,672 | $1,222 |
| Uloric | 23 | $21,728 | $945 |
| Calcium Acetate | 108 | $16,016 | $148 |
| Veltassa | 12 | $10,413 | $868 |
| Furosemide | 294 | $3,631 | $12 |
| Tacrolimus | 11 | $3,213 | $292 |
| Omega-3 Acid Ethyl Esters | 15 | $2,079 | $139 |
| Losartan | 193 | $1,918 | $10 |
| Hydralazine | 80 | $1,715 | $21 |
| Sodium Polystyrene Sulfonate | 21 | $1,447 | $69 |
| Potassium Chloride | 20 | $1,404 | $70 |
| Isosorbide Dinitrate | 23 | $1,349 | $59 |
| Carvedilol | 133 | $1,292 | $10 |
| Atorvastatin | 89 | $1,230 | $14 |
| Calcitriol | 41 | $1,075 | $26 |
| Amlodipine Besylate | 172 | $1,063 | $6 |
| Fosinopril | 46 | $926 | $20 |
| Metoprolol | 18 | $781 | $43 |
| Metoprolol | 91 | $735 | $8 |
| Gabapentin | 77 | $726 | $9 |
| Sps | 12 | $716 | $60 |
| Mycophenolate Mofetil | 14 | $688 | $49 |
| Isosorbide Mononitrate Er | 23 | $668 | $29 |
| Lidocaine-Prilocaine | 20 | $656 | $33 |
| Nifedipine Er | 12 | $617 | $51 |
| Minoxidil | 12 | $432 | $36 |
| Tamsulosin | 19 | $363 | $19 |
| Omeprazole | 25 | $284 | $11 |
| Pantoprazole | 26 | $276 | $11 |
| Benazepril | 26 | $267 | $10 |
| Clonidine | 30 | $253 | $8 |
| Allopurinol | 16 | $179 | $11 |
| Lactulose | 13 | $133 | $10 |
| Heparin | 22 | $108 | $5 |
| Glipizide | 23 | $107 | $5 |
| Trazodone | 17 | $89 | $5 |
| Famotidine | 16 | $54 | $3 |
2017: 44 drugs
| Sensipar | 135 | $252,029 | $1,867 |
| Renvela | 70 | $235,297 | $3,361 |
| Fosrenol | 15 | $27,078 | $1,805 |
| Calcium Acetate | 98 | $21,703 | $221 |
| Uloric | 20 | $15,733 | $787 |
| Tacrolimus | 17 | $5,617 | $330 |
| Clonidine | 23 | $4,712 | $205 |
| Isosorbide Dinitrate | 34 | $4,522 | $133 |
| Novolog Flexpen | 11 | $3,134 | $285 |
| Sodium Polystyrene Sulfonate | 32 | $2,926 | $91 |
| Kionex | 24 | $2,926 | $122 |
| Furosemide | 313 | $2,775 | $9 |
| Hydralazine | 104 | $2,511 | $24 |
| Omega-3 Acid Ethyl Esters | 14 | $2,366 | $169 |
| Mycophenolate Mofetil | 15 | $1,466 | $98 |
| Atorvastatin | 105 | $1,419 | $14 |
| Losartan | 154 | $1,382 | $9 |
| Potassium Chloride | 14 | $1,294 | $92 |
| Fosinopril | 66 | $1,142 | $17 |
| Amlodipine Besylate | 157 | $1,047 | $7 |
| Metoprolol | 109 | $869 | $8 |
| Labetalol | 13 | $843 | $65 |
| Calcitriol | 21 | $795 | $38 |
| Carvedilol | 68 | $676 | $10 |
| Nifedipine Er | 12 | $633 | $53 |
| Gabapentin | 71 | $541 | $8 |
| Lidocaine-Prilocaine | 14 | $473 | $34 |
| Minoxidil | 16 | $465 | $29 |
| Isosorbide Mononitrate Er | 15 | $447 | $30 |
| Metoprolol | 14 | $426 | $30 |
| Omeprazole | 37 | $378 | $10 |
| Prednisone | 21 | $368 | $18 |
| Tamsulosin | 14 | $363 | $26 |
| Gentamicin Sulfate | 11 | $355 | $32 |
| Pravastatin | 12 | $334 | $28 |
| Clonidine | 30 | $270 | $9 |
| Benazepril | 27 | $233 | $9 |
| Levothyroxine | 11 | $206 | $19 |
| Pantoprazole | 23 | $205 | $9 |
| Glipizide | 19 | $131 | $7 |
| Trazodone | 29 | $118 | $4 |
| Lactulose | 21 | $96 | $5 |
| Heparin | 19 | $72 | $4 |
| Alendronate | 12 | $51 | $4 |
2016: 41 drugs
| Renvela | 78 | $229,387 | $2,941 |
| Sensipar | 106 | $211,116 | $1,992 |
| Renagel | 25 | $102,096 | $4,084 |
| Fosrenol | 25 | $39,673 | $1,587 |
| Calcium Acetate | 97 | $18,822 | $194 |
| Clonidine | 44 | $8,581 | $195 |
| Omega-3 Acid Ethyl Esters | 23 | $5,333 | $232 |
| Isosorbide Dinitrate | 24 | $3,847 | $160 |
| Lantus | 13 | $2,820 | $217 |
| Humalog | 11 | $2,432 | $221 |
| Colchicine | 12 | $2,236 | $186 |
| Furosemide | 238 | $2,020 | $8 |
| Kionex | 17 | $1,954 | $115 |
| Eplerenone | 14 | $1,831 | $131 |
| Tamsulosin | 27 | $1,389 | $51 |
| Hydralazine | 48 | $1,346 | $28 |
| Atorvastatin | 85 | $1,326 | $16 |
| Losartan | 146 | $1,321 | $9 |
| Fosinopril | 56 | $947 | $17 |
| Calcitriol | 14 | $831 | $59 |
| Amlodipine Besylate | 127 | $780 | $6 |
| Carvedilol | 84 | $731 | $9 |
| Lidocaine-Prilocaine | 22 | $695 | $32 |
| Metoprolol | 92 | $686 | $7 |
| Gabapentin | 67 | $510 | $8 |
| Omeprazole | 27 | $482 | $18 |
| Sodium Citrate & Citric Acid | 18 | $391 | $22 |
| Clonidine | 24 | $305 | $13 |
| Allopurinol | 17 | $244 | $14 |
| Minoxidil | 12 | $242 | $20 |
| Levothyroxine | 14 | $229 | $16 |
| Pantoprazole | 14 | $171 | $12 |
| Benazepril | 21 | $163 | $8 |
| Lisinopril | 12 | $103 | $9 |
| Glipizide | 12 | $95 | $8 |
| Hydrochlorothiazide | 16 | $80 | $5 |
| Hydroxyzine | 11 | $76 | $7 |
| Clopidogrel | 11 | $74 | $7 |
| Simvastatin | 11 | $49 | $4 |
| Famotidine | 15 | $46 | $3 |
| Lactulose | 11 | $44 | $4 |
2015: 43 drugs
| Sensipar | 126 | $208,877 | $1,658 |
| Renvela | 68 | $172,231 | $2,533 |
| Renagel | 22 | $55,690 | $2,531 |
| Fosrenol | 14 | $21,538 | $1,538 |
| Calcium Acetate | 96 | $20,429 | $213 |
| Clonidine | 41 | $10,395 | $254 |
| Omega-3 Acid Ethyl Esters | 12 | $5,002 | $417 |
| Prosol | 26 | $4,422 | $170 |
| Isosorbide Dinitrate | 23 | $4,161 | $181 |
| Lantus | 12 | $3,480 | $290 |
| Eplerenone | 12 | $2,273 | $189 |
| Clinisol | 20 | $2,079 | $104 |
| Furosemide | 227 | $2,023 | $9 |
| Kionex | 13 | $1,590 | $122 |
| Tamsulosin | 32 | $1,515 | $47 |
| Lidocaine-Prilocaine | 41 | $1,420 | $35 |
| Losartan | 123 | $1,329 | $11 |
| Potassium Chloride | 18 | $1,250 | $69 |
| Atorvastatin | 73 | $1,194 | $16 |
| Hydralazine | 51 | $1,191 | $23 |
| Amlodipine Besylate | 123 | $855 | $7 |
| Omeprazole | 47 | $854 | $18 |
| Metoprolol | 117 | $804 | $7 |
| Carvedilol | 88 | $619 | $7 |
| Gabapentin | 61 | $528 | $9 |
| Pravastatin | 19 | $526 | $28 |
| Fosinopril | 30 | $454 | $15 |
| Pantoprazole | 15 | $383 | $26 |
| Allopurinol | 20 | $336 | $17 |
| Sodium Citrate & Citric Acid | 15 | $319 | $21 |
| Hydroxyzine | 16 | $317 | $20 |
| Clonidine | 26 | $293 | $11 |
| Levothyroxine | 19 | $280 | $15 |
| Hydromorphone | 29 | $241 | $8 |
| Benazepril | 25 | $224 | $9 |
| Prednisone | 12 | $128 | $11 |
| Lactulose | 19 | $124 | $7 |
| Clopidogrel | 18 | $122 | $7 |
| Simvastatin | 24 | $121 | $5 |
| Trazodone | 20 | $115 | $6 |
| Hydrochlorothiazide | 19 | $92 | $5 |
| Levetiracetam | 11 | $85 | $8 |
| Famotidine | 23 | $83 | $4 |
2014: 41 drugs
| Sensipar | 78 | $154,985 | $1,987 |
| Renvela | 52 | $104,470 | $2,009 |
| Calcium Acetate | 69 | $19,906 | $288 |
| Fosrenol | 11 | $11,195 | $1,018 |
| Clonidine | 38 | $10,174 | $268 |
| Isosorbide Dinitrate | 15 | $2,712 | $181 |
| Potassium Chloride | 24 | $2,527 | $105 |
| Humalog | 12 | $2,229 | $186 |
| Novolog Mix 70-30 | 11 | $2,062 | $187 |
| Kionex | 15 | $1,788 | $119 |
| Atorvastatin | 71 | $1,557 | $22 |
| Losartan | 107 | $1,522 | $14 |
| Furosemide | 162 | $1,368 | $8 |
| Amlodipine Besylate | 127 | $1,207 | $10 |
| Omeprazole | 47 | $1,106 | $24 |
| Hydralazine | 30 | $1,105 | $37 |
| Calcitriol | 21 | $995 | $47 |
| Metoprolol | 122 | $993 | $8 |
| Tamsulosin | 29 | $950 | $33 |
| Lidocaine-Prilocaine | 23 | $701 | $30 |
| Gabapentin | 70 | $641 | $9 |
| Carvedilol | 42 | $555 | $13 |
| Fosinopril | 33 | $541 | $16 |
| Minoxidil | 21 | $443 | $21 |
| Benazepril | 27 | $431 | $16 |
| Clonidine | 26 | $371 | $14 |
| Hydromorphone | 34 | $305 | $9 |
| Fluticasone Propionate | 19 | $288 | $15 |
| Glipizide | 22 | $282 | $13 |
| Levothyroxine | 12 | $256 | $21 |
| Trazodone | 24 | $176 | $7 |
| Hydroxyzine | 12 | $148 | $12 |
| Simvastatin | 21 | $148 | $7 |
| Famotidine | 22 | $126 | $6 |
| Prednisone | 12 | $125 | $10 |
| Lactulose | 13 | $115 | $9 |
| Heparin | 14 | $105 | $8 |
| Lisinopril | 11 | $99 | $9 |
| Allopurinol | 16 | $92 | $6 |
| Zolpidem | 11 | $85 | $8 |
| Alendronate | 13 | $68 | $5 |
2013: 42 drugs
| Sensipar | 112 | $157,555 | $1,407 |
| Renvela | 52 | $71,493 | $1,375 |
| Calcium Acetate | 91 | $19,278 | $212 |
| Lovaza | 12 | $6,296 | $525 |
| Clonidine | 16 | $5,267 | $329 |
| Cyclosporine | 12 | $3,311 | $276 |
| Baraclude | 11 | $3,057 | $278 |
| Clinisol | 26 | $2,900 | $112 |
| Losartan | 77 | $2,609 | $34 |
| Furosemide | 223 | $2,415 | $11 |
| Atorvastatin | 55 | $2,108 | $38 |
| Mycophenolate Mofetil | 15 | $2,057 | $137 |
| Isosorbide Dinitrate | 12 | $2,055 | $171 |
| Calcitriol | 30 | $1,628 | $54 |
| Potassium Chloride | 20 | $1,577 | $79 |
| Metoprolol | 113 | $1,282 | $11 |
| Amlodipine Besylate | 118 | $1,234 | $10 |
| Tamsulosin | 31 | $933 | $30 |
| Omeprazole | 25 | $771 | $31 |
| Benazepril | 40 | $756 | $19 |
| Labetalol | 11 | $551 | $50 |
| Gabapentin | 44 | $495 | $11 |
| Clonidine | 36 | $476 | $13 |
| Pravastatin | 20 | $396 | $20 |
| Lidocaine-Prilocaine | 12 | $349 | $29 |
| Hydralazine | 13 | $344 | $26 |
| Simvastatin | 26 | $325 | $13 |
| Azathioprine | 23 | $319 | $14 |
| Metoprolol | 12 | $278 | $23 |
| Lactulose | 16 | $234 | $15 |
| Hydromorphone | 14 | $233 | $17 |
| Levothyroxine | 14 | $225 | $16 |
| Fosinopril | 19 | $220 | $12 |
| Hydroxyzine | 11 | $209 | $19 |
| Polyethylene Glycol 3350 | 13 | $206 | $16 |
| Chlorthalidone | 12 | $204 | $17 |
| Zolpidem | 30 | $203 | $7 |
| Glipizide | 16 | $185 | $12 |
| Trazodone | 23 | $158 | $7 |
| Prednisone | 27 | $126 | $5 |
| Allopurinol | 20 | $121 | $6 |
| Acyclovir | 12 | $67 | $6 |
Money from drug and device companies
$26 in 2019
A payment is not proof that care is biased.
| Medtronic Vascular | Endurant | $26 | 1 payment
|
See the published payment
| Medtronic Vascular | Meals · 2019-02-07 | Endurant | $26 |
Professional record
- NPI
- 1568408763
- Licence
- CA A79286, CA H94893California A79286: Current · expires 2027-11-30
- Trained
- University of California, San Francisco School of Medicine, 2000
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RN0300X (207RN0300X); Internal medicine (207R00000X)
- Mailing address
- 6331 Cottle Rd, San Jose, CA, 95123
- NPI first listed
- 2006-06-22
- NPI last updated
- 2025-09-11
This is when the NPI record was last certified, not a medical board exam.